Polysaccharides have received extensive attention due to their multiple physiological functions, especially their remarkable antioxidant capacity. In this study, a novel acidic polysaccharide (PSMP-2) with a molecular weight (Mw) of 1.28 × 10 Da from Bunge was extracted and purified via DEAE-52 cellulose column and Sephadex G-100 column chromatography. The structure of PSMP-2 was characterised by high-performance gel permeation chromatography (HPGPC), high-performance liquid chromatography (HPLC), Fourier transforms infrared spectroscopy (FT-IR) and methylation analysis. The results showed that PSMP-2 was an acidic heteropolysaccharide composed of rhamnose (Rha) (6.15%), galacturonic acid (GalA) (55.98%), and galactose (Gal) (21.27%) and arabinose (Ara) (16.69%). PSMP-2 contained five major glycosidic linkages, (1→)-linked-Ara, (1→2, 4)-linked-Rha, (1→4)-linked-Gal, (1→6)-linked-Gal, (1→3, 6)-linked-Gal, in a molar ratio of 5.98: 1.45: 72.23: 16.40: 3.94. The IC of PSMP-2 on 2, 2-Diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl free radical scavenging ability were 0.991 mg/mL and 4.007 mg/mL, respectively. It could regulate the activity of antioxidant enzymes in vivo and had good antioxidant activity. To sum up, a novel acidic polysaccharide (Mw of 1.28 × 10 Da) with antioxidant activity was isolated from , and its application prospect in the field of medicine and food was preliminarily revealed.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14786419.2022.2096605DOI Listing

Publication Analysis

Top Keywords

novel acidic
8
acidic polysaccharide
8
antioxidant activity
8
antioxidant
5
psmp-2
5
structural characterisation
4
characterisation antioxidant
4
antioxidant activities
4
activities in vitro
4
in vitro in vivo
4

Similar Publications

Metabolomics provide a promising tool for understanding dementia pathogenesis and identifying novel biomarkers. This study aimed to identify amino acid biomarkers for Alzheimer's Disease (AD) and Vascular Dementia (VD). By amino acid metabolomics, the concentrations of amino acids were determined in the serum of AD and VD patients as well as age-matched healthy controls.

View Article and Find Full Text PDF

Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.

Cell Mol Life Sci

January 2025

Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Unitat de Farmacologia, Universitat de Barcelona, Av. Joan XXIII 27-31, 08028, Barcelona, Spain.

Nuclear growth differentiation factor 15 (GDF15) reduces the binding of the mothers' against decapentaplegic homolog (SMAD) complex to its DNA-binding elements. However, the stimuli that control this process are unknown. Here, we examined whether saturated fatty acids (FA), particularly palmitate, regulate nuclear GDF15 levels and the activation of the SMAD3 pathway in human skeletal myotubes and mouse skeletal muscle, where most insulin-stimulated glucose use occurs in the whole organism.

View Article and Find Full Text PDF

An aerobic, Gram-stain-positive, motile, coccus-shaped actinomycete, designated strain LSe6-4, was isolated from leaves of sea purslane (Sesuvium portulacastrum L.) in Thailand and subjected to a polyphasic taxonomic studies. Growth of the strain occurred at temperatures between 15 and 38 °C, and with NaCl concentrations 0-13%.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) plaques in the brain, contributing to neurodegeneration. This study investigates lipid alterations within these plaques using a novel, label-free, multimodal approach. Combining infrared (IR) imaging, machine learning, laser microdissection (LMD), and flow injection analysis mass spectrometry (FIA-MS), we provide the first comprehensive lipidomic analysis of chemically unaltered Aβ plaques in post-mortem human AD brain tissue.

View Article and Find Full Text PDF

Background: Atherosclerosis (AS) is increasingly recognized as a chronic inflammatory disease that significantly compromises vascular health and acts as a major contributor to cardiovascular diseases. Advancements in lipidomics and metabolomics have unveiled the complex role of fatty acid metabolism (FAM) in both healthy and pathological states. However, the specific roles of fatty acid metabolism-related genes (FAMGs) in shaping therapeutic approaches, especially in AS, remain largely unexplored and are a subject of ongoing research.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!